Skip to main content
PMC home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1987 Jul;69(1):1–9.

Progress in the immunology of the mycobacterioses.

G A Rook 1
PMCID: PMC1542249  PMID: 3308222

Full text

PDF
1

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abou-Zeid C., Smith I., Grange J., Steele J., Rook G. Subdivision of daughter strains of bacille Calmette-Guérin (BCG) according to secreted protein patterns. J Gen Microbiol. 1986 Nov;132(11):3047–3053. doi: 10.1099/00221287-132-11-3047. [DOI] [PubMed] [Google Scholar]
  2. Amos H. E., Lachmann P. J. The immunological specificity of a macrophage inhibition factor. Immunology. 1970 Feb;18(2):269–278. [PMC free article] [PubMed] [Google Scholar]
  3. Barnass S., Mace J., Steele J., Torres P., Gervasoni B., Ravioli R., Terencio J., Rook G. A., Waters M. F. Prevalence and specificity of the enhancing effect of three types of interleukin 2 on T cell responsiveness in 97 lepromatous leprosy patients of mixed ethnic origin. Clin Exp Immunol. 1986 Apr;64(1):41–49. [PMC free article] [PubMed] [Google Scholar]
  4. Beutler B. A., Cerami A. Recombinant interleukin 1 suppresses lipoprotein lipase activity in 3T3-L1 cells. J Immunol. 1985 Dec;135(6):3969–3971. [PubMed] [Google Scholar]
  5. Beutler B., Cerami A. Cachectin and tumour necrosis factor as two sides of the same biological coin. Nature. 1986 Apr 17;320(6063):584–588. doi: 10.1038/320584a0. [DOI] [PubMed] [Google Scholar]
  6. Beutler B., Milsark I. W., Cerami A. C. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science. 1985 Aug 30;229(4716):869–871. doi: 10.1126/science.3895437. [DOI] [PubMed] [Google Scholar]
  7. Bevilacqua M. P., Pober J. S., Majeau G. R., Fiers W., Cotran R. S., Gimbrone M. A., Jr Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: characterization and comparison with the actions of interleukin 1. Proc Natl Acad Sci U S A. 1986 Jun;83(12):4533–4537. doi: 10.1073/pnas.83.12.4533. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Brincourt J. Le calciférol a-t-il une action liquéfiante sur le caséum. Poumon Coeur. 1967;23(7):841–851. [PubMed] [Google Scholar]
  9. Brown J. A., Stone M. M., Sutherland I. B.C.G. vaccination of children against leprosy in Uganda: results at end of second follow-up. Br Med J. 1968 Jan 6;1(5583):24–27. doi: 10.1136/bmj.1.5583.24. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Chedid L. Synthetic muramyl peptides: their origin, present status, and future prospects. Introductory remarks. Fed Proc. 1986 Oct;45(11):2531–2533. [PubMed] [Google Scholar]
  11. Crowle A. J., May M. Preliminary demonstration of human tuberculoimmunity in vitro. Infect Immun. 1981 Jan;31(1):453–464. doi: 10.1128/iai.31.1.453-464.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Davies P. D. A possible link between vitamin D deficiency and impaired host defence to Mycobacterium tuberculosis. Tubercle. 1985 Dec;66(4):301–306. doi: 10.1016/0041-3879(85)90068-6. [DOI] [PubMed] [Google Scholar]
  13. Dinarello C. A., Cannon J. G., Wolff S. M., Bernheim H. A., Beutler B., Cerami A., Figari I. S., Palladino M. A., Jr, O'Connor J. V. Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1. J Exp Med. 1986 Jun 1;163(6):1433–1450. doi: 10.1084/jem.163.6.1433. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Douvas G. S., Looker D. L., Vatter A. E., Crowle A. J. Gamma interferon activates human macrophages to become tumoricidal and leishmanicidal but enhances replication of macrophage-associated mycobacteria. Infect Immun. 1985 Oct;50(1):1–8. doi: 10.1128/iai.50.1.1-8.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Edwards M. L., Goodrich J. M., Muller D., Pollack A., Ziegler J. E., Smith D. W. Infection with Mycobacterium avium-intracellulare and the protective effects of Bacille Calmette-Guérin. J Infect Dis. 1982 May;145(5):733–741. doi: 10.1093/infdis/145.2.733. [DOI] [PubMed] [Google Scholar]
  16. Emmrich F., Thole J., van Embden J., Kaufmann S. H. A recombinant 64 kilodalton protein of Mycobacterium bovis bacillus Calmette-Guerin specifically stimulates human T4 clones reactive to mycobacterial antigens. J Exp Med. 1986 Apr 1;163(4):1024–1029. doi: 10.1084/jem.163.4.1024. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Evans R., Grant C. K., Cox H., Steele K., Alexander P. Thymus-derived lymphocytes produce an immunologically specific macrophage-arming factor. J Exp Med. 1972 Nov 1;136(5):1318–1322. doi: 10.1084/jem.136.5.1318. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Fujiwara H., Kleinhenz M. E., Wallis R. S., Ellner J. J. Increased interleukin-1 production and monocyte suppressor cell activity associated with human tuberculosis. Am Rev Respir Dis. 1986 Jan;133(1):73–77. doi: 10.1164/arrd.1986.133.1.73. [DOI] [PubMed] [Google Scholar]
  19. Harboe M., Nagai S. MPB70, a unique antigen of Mycobacterium bovis BCG. Am Rev Respir Dis. 1984 Mar;129(3):444–452. doi: 10.1164/arrd.1984.129.3.444. [DOI] [PubMed] [Google Scholar]
  20. Haregewoin A., Godal T., Mustafa A. S., Belehu A., Yemaneberhan T. T-cell conditioned media reverse T-cell unresponsiveness in lepromatous leprosy. Nature. 1983 May 26;303(5915):342–344. doi: 10.1038/303342a0. [DOI] [PubMed] [Google Scholar]
  21. Holoshitz J., Klajman A., Drucker I., Lapidot Z., Yaretzky A., Frenkel A., van Eden W., Cohen I. R. T lymphocytes of rheumatoid arthritis patients show augmented reactivity to a fraction of mycobacteria cross-reactive with cartilage. Lancet. 1986 Aug 9;2(8502):305–309. doi: 10.1016/s0140-6736(86)90003-6. [DOI] [PubMed] [Google Scholar]
  22. Kaplan G., Weinstein D. E., Steinman R. M., Levis W. R., Elvers U., Patarroyo M. E., Cohn Z. A. An analysis of in vitro T cell responsiveness in lepromatous leprosy. J Exp Med. 1985 Sep 1;162(3):917–929. doi: 10.1084/jem.162.3.917. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Kaplan H. J., Streilein J. W. Do immunologically privileged sites require a functioning spleen? Nature. 1974 Oct 11;251(5475):553–554. doi: 10.1038/251553a0. [DOI] [PubMed] [Google Scholar]
  24. Kaufmann S. H., Chiplunkar S., Flesch I., De Libero G. Possible role of helper and cytolytic T cells in mycobacterial infections. Lepr Rev. 1986 Dec;57 (Suppl 2):101–111. doi: 10.5935/0305-7518.19860060. [DOI] [PubMed] [Google Scholar]
  25. Kops S. K., Ratzlaff R. E., Meade R., Iverson G. M., Askenase P. W. Interaction of antigen-specific T cell factors with unique "receptors" on the surface of mast cells: demonstration in vitro by an indirect rosetting technique. J Immunol. 1986 Jun 15;136(12):4515–4524. [PubMed] [Google Scholar]
  26. Lefford M. J., Morgan R., Logie P. S. Effect of Mycobacterium bovis BCG vaccination upon Mycobacterium lepraemurium infection. Infect Immun. 1980 Jun;28(3):860–866. doi: 10.1128/iai.28.3.860-866.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Martin S. A., Karnovsky M. L., Krueger J. M., Pappenheimer J. R., Biemann K. Peptidoglycans as promoters of slow-wave sleep. I. Structure of the sleep-promoting factor isolated from human urine. J Biol Chem. 1984 Oct 25;259(20):12652–12658. [PubMed] [Google Scholar]
  28. Mehra V., Brennan P. J., Rada E., Convit J., Bloom B. R. Lymphocyte suppression in leprosy induced by unique M. leprae glycolipid. Nature. 1984 Mar 8;308(5955):194–196. doi: 10.1038/308194a0. [DOI] [PubMed] [Google Scholar]
  29. Mehra V., Sweetser D., Young R. A. Efficient mapping of protein antigenic determinants. Proc Natl Acad Sci U S A. 1986 Sep;83(18):7013–7017. doi: 10.1073/pnas.83.18.7013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Modlin R. L., Kato H., Mehra V., Nelson E. E., Fan X. D., Rea T. H., Pattengale P. K., Bloom B. R. Genetically restricted suppressor T-cell clones derived from lepromatous leprosy lesions. 1986 Jul 31-Aug 6Nature. 322(6078):459–461. doi: 10.1038/322459a0. [DOI] [PubMed] [Google Scholar]
  31. Morton A., Nye P., Rook G. A., Samuel N., Stanford J. L. A further investigation of skin-test responsiveness and suppression in leprosy patients and healthy school children in Nepal. Lepr Rev. 1984 Sep;55(3):273–281. doi: 10.5935/0305-7518.19840031. [DOI] [PubMed] [Google Scholar]
  32. Mustafa A. S., Gill H. K., Nerland A., Britton W. J., Mehra V., Bloom B. R., Young R. A., Godal T. Human T-cell clones recognize a major M. leprae protein antigen expressed in E. coli. Nature. 1986 Jan 2;319(6048):63–66. doi: 10.1038/319063a0. [DOI] [PubMed] [Google Scholar]
  33. Newton R. C. Effect of interferon on the induction of human monocyte secretion of interleukin-1 activity. Immunology. 1985 Nov;56(3):441–449. [PMC free article] [PubMed] [Google Scholar]
  34. Orme I. M., Collins F. M. Crossprotection against nontuberculous mycobacterial infections by Mycobacterium tuberculosis memory immune T lymphocytes. J Exp Med. 1986 Jan 1;163(1):203–208. doi: 10.1084/jem.163.1.203. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Ottenhoff T. H., Elferink D. G., Klatser P. R., de Vries R. R. Cloned suppressor T cells from a lepromatous leprosy patient suppress Mycobacterium leprae reactive helper T cells. 1986 Jul 31-Aug 6Nature. 322(6078):462–464. doi: 10.1038/322462a0. [DOI] [PubMed] [Google Scholar]
  36. Ottenhoff T. H., Elferink D. G., de Vries R. R. Unresponsiveness to Mycobacterium leprae in lepromatous leprosy in vitro: reversible or not? Int J Lepr Other Mycobact Dis. 1984 Sep;52(3):419–424. [PubMed] [Google Scholar]
  37. Ottenhoff T. H., Klatser P. R., Ivanyi J., Elferink D. G., de Wit M. Y., de Vries R. R. Mycobacterium leprae-specific protein antigens defined by cloned human helper T cells. Nature. 1986 Jan 2;319(6048):66–68. doi: 10.1038/319066a0. [DOI] [PubMed] [Google Scholar]
  38. Ottenhoff T. H., Torres P., de las Aguas J. T., Fernandez R., van Eden W., de Vries R. R., Stanford J. L. Evidence for an HLA-DR4-associated immune-response gene for Mycobacterium tuberculosis. A clue to the pathogenesis of rheumatoid arthritis? Lancet. 1986 Aug 9;2(8502):310–313. doi: 10.1016/s0140-6736(86)90004-8. [DOI] [PubMed] [Google Scholar]
  39. Prasad H. K., Singh R., Nath I. Radiolabelled M. leprae resident in human macrophage cultures as an in vitro indicator of effective immunity in human leprosy. Clin Exp Immunol. 1982 Sep;49(3):517–522. [PMC free article] [PubMed] [Google Scholar]
  40. Rook G. A., Champion B. R., Steele J., Varey A. M., Stanford J. L. I-A restricted activation by T cell lines of anti-tuberculosis activity in murine macrophages. Clin Exp Immunol. 1985 Feb;59(2):414–420. [PMC free article] [PubMed] [Google Scholar]
  41. Rook G. A., Steele J., Ainsworth M., Champion B. R. Activation of macrophages to inhibit proliferation of Mycobacterium tuberculosis: comparison of the effects of recombinant gamma-interferon on human monocytes and murine peritoneal macrophages. Immunology. 1986 Nov;59(3):333–338. [PMC free article] [PubMed] [Google Scholar]
  42. Rook G. A., Steele J., Barnass S., Mace J., Stanford J. L. Responsiveness to live M. tuberculosis, and common antigens, of sonicate-stimulated T cell lines from normal donors. Clin Exp Immunol. 1986 Jan;63(1):105–110. [PMC free article] [PubMed] [Google Scholar]
  43. Rook G. A., Steele J., Fraher L., Barker S., Karmali R., O'Riordan J., Stanford J. Vitamin D3, gamma interferon, and control of proliferation of Mycobacterium tuberculosis by human monocytes. Immunology. 1986 Jan;57(1):159–163. [PMC free article] [PubMed] [Google Scholar]
  44. Rook G. A., Stewart-Tull D. E. The dissociation of adjuvant properties of mycobacterial components from mitogenicity, and from the ability to induce the release of mediators from macrophages. Immunology. 1976 Sep;31(3):389–396. [PMC free article] [PubMed] [Google Scholar]
  45. Rook G. A. Suppressor cells of mouse and man. What is the evidence that they contribute to the aetiology of the mycobacterioses? Lepr Rev. 1982 Dec;53(4):306–312. doi: 10.5935/0305-7518.19820038. [DOI] [PubMed] [Google Scholar]
  46. Salgame P. R., Mahadevan P. R., Antia N. H. Mechanism of immunosuppression in leprosy: presence of suppressor factor(s) from macrophages of lepromatous patients. Infect Immun. 1983 Jun;40(3):1119–1126. doi: 10.1128/iai.40.3.1119-1126.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Sathish M., Bhutani L. K., Sharma A. K., Nath I. Monocyte-derived soluble suppressor factor(s) in patients with lepromatous leprosy. Infect Immun. 1983 Dec;42(3):890–899. doi: 10.1128/iai.42.3.890-899.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Steele J., Flint K. C., Pozniak A. L., Hudspith B., Johnson M. M., Rook G. A. Inhibition of virulent Mycobacterium tuberculosis by murine peritoneal macrophages and human alveolar lavage cells: the effects of lymphokines and recombinant gamma interferon. Tubercle. 1986 Dec;67(4):289–294. doi: 10.1016/0041-3879(86)90018-8. [DOI] [PubMed] [Google Scholar]
  49. Stoner G. L. Importance of the neural predilection of Mycobacterium leprae in leprosy. Lancet. 1979 Nov 10;2(8150):994–996. doi: 10.1016/s0140-6736(79)92564-9. [DOI] [PubMed] [Google Scholar]
  50. Walker L., Lowrie D. B. Killing of Mycobacterium microti by immunologically activated macrophages. Nature. 1981 Sep 3;293(5827):69–71. doi: 10.1038/293069a0. [DOI] [PubMed] [Google Scholar]
  51. Young D. B., Lamb J. R. T lymphocytes respond to solid-phase antigen: a novel approach to the molecular analysis of cellular immunity. Immunology. 1986 Oct;59(2):167–171. [PMC free article] [PubMed] [Google Scholar]
  52. Young R. A., Mehra V., Sweetser D., Buchanan T., Clark-Curtiss J., Davis R. W., Bloom B. R. Genes for the major protein antigens of the leprosy parasite Mycobacterium leprae. Nature. 1985 Aug 1;316(6027):450–452. doi: 10.1038/316450a0. [DOI] [PubMed] [Google Scholar]
  53. van Eden W., Holoshitz J., Nevo Z., Frenkel A., Klajman A., Cohen I. R. Arthritis induced by a T-lymphocyte clone that responds to Mycobacterium tuberculosis and to cartilage proteoglycans. Proc Natl Acad Sci U S A. 1985 Aug;82(15):5117–5120. doi: 10.1073/pnas.82.15.5117. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES